Nanog antibody [N3C3]
GTX100863
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mammals, Mouse
TargetNANOG
Overview
- SupplierGeneTex
- Product NameNanog antibody [N3C3]
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IP: 1:100-1:500. ELISA: 1:1000-1:10000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.5 mg/ml
- ConjugateUnconjugated
- Gene ID79923
- Target nameNANOG
- Target descriptionNanog homeobox
- Target synonymshomeobox protein NANOG; homeobox transcription factor Nanog; homeobox transcription factor Nanog-delta 48
- HostRabbit
- IsotypeIgG
- Protein IDQ9H9S0
- Protein NameHomeobox protein NANOG
- Scientific DescriptionTranscription regulator involved in inner cell mass and embryonic stem (ES) cells proliferation and self-renewal. Imposes pluripotency on ES cells and prevents their differentiation towards extraembryonic endoderm and trophectoderm lineages. Blocks bone morphogenetic protein-induced mesoderm differentiation of ES cells by physically interacting with SMAD1 and interfering with the recruitment of coactivators to the active SMAD transcriptional complexes (By similarity). Acts as a transcriptional activator or repressor (By similarity). Binds optimally to the DNA consensus sequence 5-TAAT[GT][GT]-3 or 5-[CG][GA][CG]C[GC]ATTAN[GC]-3 (By similarity). When overexpressed, promotes cells to enter into S phase and proliferation.
- ReactivityHuman, Mammals, Mouse
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma.Read more
- Heparanase regulates EMT and cancer stem cell properties in prostate tumors.Read more
- Cis-regulatory chromatin loops analysis identifies GRHL3 as a master regulator of surface epithelium commitment. Huang H et al., 2022 Jul 15, Sci AdvRead more
- The aqueous extract of brucea javanica reduces tumorigenicity of human lung cancer tumorspheres. Kim SH et al., 2021, Cancer Drug ResistRead more
- Transcription Factor 4 loss-of-function is associated with deficits in progenitor proliferation and cortical neuron content. Papes F et al., 2022 May 2, Nat CommunRead more
- Generation of a DKK2 homozygous knockout human embryonic stem cell line using the CRISPR/Cas9 system. Zhang W et al., 2021 Nov 24, Stem Cell ResRead more
- Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells.Read more
- Selective Proliferation of Highly Functional Adipose-Derived Stem Cells in Microgravity Culture with Stirred Microspheres. Mashiko T et al., 2021 Mar 4, CellsRead more
- CCAAT/Enhancer-binding protein delta mediates glioma stem-like cell enrichment and ATP-binding cassette transporter ABCA1 activation for temozolomide resistance in glioblastoma. Wang SM et al., 2021 Jan 12, Cell Death DiscovRead more
- Neural precursors cells expanded in a 3D micro-engineered niche present enhanced therapeutic efficacy in vivo. Carelli S et al., 2021, NanotheranosticsRead more